4.7 Article

OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

LOX-1 and cancer: an indissoluble liaison

M. Murdocca et al.

Summary: Recent studies have demonstrated a strong correlation between metabolic disorders, tumor onset, and progression, leading to the exploration of new therapeutic strategies targeting metabolic targets. The OLR1 gene encodes the LOX-1 receptor protein, which has been shown to be involved in atherosclerosis and more recently in various tumors. Upregulation of LOX-1 in tumors has been linked to cancer initiation, progression, and metastasis, indicating it as a promising therapeutic target for enhancing current antineoplastic strategies.

CANCER GENE THERAPY (2021)

Article Oncology

Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma

Naomichi Koga et al.

Summary: High expression of SIRP alpha is associated with poor prognosis in ESCC patients, as well as with tumor invasion depth and infiltration of immune cells. The co-expression of SIRP alpha and PD-L1 may lead to worse outcomes for patients.

CANCER SCIENCE (2021)

Article Biochemistry & Molecular Biology

C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake

Dongmei Wang et al.

ONCOGENE (2020)

Review Cell Biology

Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer

Marteinn Thor Snaebjornsson et al.

CELL METABOLISM (2020)

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Hematology

Neutrophil plasticity in the tumor microenvironment

Morgan A. Giese et al.

BLOOD (2019)

Review Medicine, General & Internal

Breast Cancer Treatment A Review

Adrienne G. Waks et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Biochemistry & Molecular Biology

Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages

Manman Guo et al.

EMBO JOURNAL (2019)

Review Immunology

Targeting Tumor-Associated Macrophages in Cancer

Paulina Pathria et al.

TRENDS IN IMMUNOLOGY (2019)

Review Oncology

The Tumor Microenvironment Innately Modulates Cancer Progression

Dominique C. Hinshaw et al.

CANCER RESEARCH (2019)

Review Immunology

Targeting Treg cells in cancer immunotherapy

Atsushi Tanaka et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Biochemistry & Molecular Biology

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Suhas V. Vasaikar et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Medicine, Research & Experimental

LOX-1 receptor: A potential link in atherosclerosis and cancer

Silvana Balzan et al.

LIFE SCIENCES (2018)

Review Cell Biology

Regulatory T cells in cancer immunotherapy

Atsushi Tanaka et al.

CELL RESEARCH (2017)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Immunology

Molecular and cellular insights into T cell exhaustion

E. John Wherry et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Review Cell Biology

Cellular Fatty Acid Metabolism and Cancer

Erin Currie et al.

CELL METABOLISM (2013)

Article Immunology

Tumor associated macrophages and neutrophils in cancer

Maria Rosaria Galdiero et al.

IMMUNOBIOLOGY (2013)

Review Immunology

Innate and adaptive immune cells in the tumor microenvironment

Thomas F. Gajewski et al.

NATURE IMMUNOLOGY (2013)

Review Cell Biology

LOX-1, OxLDL, and Atherosclerosis

Angela Pirillo et al.

MEDIATORS OF INFLAMMATION (2013)

Article Oncology

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Pascal Jezequel et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)